|
1
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamamoto T, Kajino K, Kudo M, Sasaki Y,
Arakawa Y and Hino O: Determination of the clonal origin of
multiple human hepatocellular carcinomas by cloning and polymerase
chain reaction of the integrated hepatitis B virus DNA. Hepatology.
29:1446–1452. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Komatsu S, Fukumoto T, Demizu Y, Miyawaki
D, Terashima K, Sasaki R, Hori Y, Hishikawa Y, Ku Y and Murakami M:
Clinical results and risk factors of proton and carbon ion therapy
for hepatocellular carcinoma. Cancer. 117:4890–4904. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawashima M, Kohno R, Nakachi K, Nishio T,
Mitsunaga S, Ikeda M, Konishi M, Takahashi S, Gotohda N, Arahira S,
et al: Dose-volume histogram analysis of the safety of proton beam
therapy for unresectable hepatocellular carcinoma. Int J Radiat
Oncol Biol Phys. 79:1479–1486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chadha AS, Gunther JR, Hsieh CE, Aliru M,
Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ,
et al: Proton beam therapy outcomes for localized unresectable
hepatocellular carcinoma. Radiother Oncol. 133:54–61. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizumoto M, Okumura T, Hashimoto T, Fukuda
K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ookawa A,
et al: Proton beam therapy for hepatocellular carcinoma: A
comparison of three treatment protocols. Int J Radiat Oncol Biol
Phys. 81:1039–1045. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiba T, Tokuuye K, Matsuzaki Y, Sugahara
S, Chuganji Y, Kagei K, Shoda J, Hata M, Abei M, Igaki H, et al:
Proton beam therapy for hepatocellular carcinoma: A retrospective
review of 162 patients. Clin Cancer Res. 11:3799–3805. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukumitsu N, Sugahara S, Nakayama H,
Fukuda K, Mizumoto M, Abei M, Shoda J, Thono E, Tsuboi K and
Tokuuye K: A prospective study of hypofractionated proton beam
therapy for patients with hepatocellular carcinoma. Int J Radiat
Oncol Biol Phys. 74:831–836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishikawa H, Osaki Y, Iguchi E, Takeda H,
Ohara Y, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R and Kimura
T: Percutaneous radiofrequency ablation therapy for recurrent
hepatocellular carcinoma. Anticancer Res. 32:5059–5065.
2012.PubMed/NCBI
|
|
10
|
Joliat GR, Allemann P, Labgaa I,
Demartines N and Halkic N: Treatment and outcomes of recurrent
hepatocellular carcinomas. Langenbecks Arch Surg. 402:737–744.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lo CH, Huang WY, Lin KT, Lin MJ, Lin TP
and Jen YM: Repeated stereotactic ablative radiotherapy using
CyberKnife for patients with hepatocellular carcinoma. J
Gastroenterol Hepatol. 29:1919–1925. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sanuki N, Takeda A, Oku Y, Eriguchi T,
Nishimura S, Aoki Y and Kunieda E: Influence of liver toxicities on
prognosis after stereotactic body radiation therapy for
hepatocellular carcinoma. Hepatol Res. 45:540–547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ingold JA, Reed GB, Kaplan HS and Bagshaw
MA: Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med.
93:200–208. 1965.PubMed/NCBI
|
|
14
|
Emami B, Lyman J, Brown A, Coia L, Goitein
M, Munzenrider JE, Shank B, Solin LJ and Wesson M: Tolerance of
normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol
Phys. 21:109–122. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizumoto M, Okumura T, Hashimoto T, Fukuda
K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ohkawa A,
et al: Evaluation of liver function after proton beam therapy for
hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
82:e529–e535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsieh CE, Venkatesulu BP, Lee CH, Hung SP,
Wong PF, Aithala SP, Kim BK, Rao A, Tung-Chieh Chang J, Tsang NM,
et al: Predictors of radiation-induced liver disease in eastern and
western patients with hepatocellular carcinoma undergoing proton
beam therapy. Int J Radiat Oncol Biol Phys. S0360-3016(19)30264-0.
Feb 21–2019.(Epub ahead of print). View Article : Google Scholar
|
|
17
|
Hashimoto T, Tokuuye K, Fukumitsu N, Igaki
H, Hata M, Kagei K, Sugahara S, Ohara K, Matsuzaki Y and Akine Y:
Repeated proton beam therapy for hepatocellular carcinoma. Int J
Radiat Oncol Biol Phys. 65:196–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oshiro Y, Mizumoto M, Okumura T, Fukuda K,
Fukumitsu N, Abei M, Ishikawa H, Takizawa D and Sakurai H: Analysis
of repeated proton beam therapy for patients with hepatocellular
carcinoma. Radiother Oncol. 123:240–245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fukumitsu N, Takahashi S, Okumura T,
Ishida T, Murofushi KN, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K
and Sakurai H: Normal liver tissue change after proton beam
therapy. Jpn J Radiol. 36:559–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
